Pacira Biosciences, Inc. (PCRX)
36.36
+0.02
(+0.06%)
USD |
NASDAQ |
Oct 19, 14:43
Pacira Biosciences Cash from Operations (Annual) : 151.99M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 151.99M |
| December 31, 2024 | 189.39M |
| December 31, 2023 | 154.65M |
| December 31, 2022 | 145.27M |
| December 31, 2021 | 125.72M |
| December 31, 2020 | 77.03M |
| December 31, 2019 | 70.52M |
| December 31, 2018 | 48.87M |
| December 31, 2017 | 17.78M |
| December 31, 2016 | 33.45M |
| Date | Value |
|---|---|
| December 31, 2015 | 26.79M |
| December 31, 2014 | 26.44M |
| December 31, 2013 | -42.78M |
| December 31, 2012 | -69.05M |
| December 31, 2011 | -31.00M |
| December 31, 2010 | -24.88M |
| December 31, 2009 | -20.84M |
| December 31, 2008 | -29.19M |
| December 31, 2007 | -13.44M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Viatris, Inc. | 2.316B |
| Johnson & Johnson | 24.53B |
| Liquidia Corp. | -35.69M |
| Organon & Co. | 700.00M |
| ANI Pharmaceuticals, Inc. | 185.22M |